LIRENTELIMAB

UNII: SWS48LJU3T
Preferred Substance Name: LIRENTELIMAB

2283348-97-8
AK002
AK-002
ANTOLIMAB
IMMUNOGLOBULIN G1, ANTI-(HUMAN SIALIC ACID-BINDINGE IG-LIKE LECTIN 8) (HUMAN-MUS MUSCULUS MONOCLONAL AK002 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL AK002 .KAPPA.-CHAIN, DIMER
LIRENTELIMAB [INN]
LIRENTELIMAB [USAN]
LIRENTELIMAB [WHO-DD]
MONOCLONAL ANTIBODY AK002

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

LIRENTELIMAB

Synonyms and Mappings

Resources

Note